Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Workflows to Realize the Greatest Benefit in oHCM and Beyond
Unfolding Advanced Light Chain (AL) Amyloidosis with Cardiac Dysfunction: From Diagnostic Challenges to Emerging Therapies
A Review of Long-Term Outcomes for Cardiac Myosin Inhibition in Adults with NYHA Class II-III Obstructive HCM
